Homeoproteins as novel therapies for neurodegenerative diseases

Project Information

HOMEOBRAIN

Grant agreement ID: 190105256

DOI

10.3030/190105256

Project closed

EC signature date 24 October 2022

Start date 1 November 2022

End date 31 October 2024

Funded under

• The European Innovation Council (EIC)

Total cost

€ 5 523 750,00

EU contribution

€ 2 500 000,00

Coordinated by

BRAINEVER
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (2)

Therapeutic value of homeoprotein signaling pathways

Author(s): Ariel A. Di Nardo, Alain Prochiantz
Published in: Frontiers in Neuroscience, Issue 18, 2024, ISSN 1662-453X
Publisher: Frontiers Media SA
DOI: 10.3389/fnins.2024.1359523

ENGRAILED-1 transcription factor has a paracrine neurotrophic activity on adult spinal α-motoneurons

Author(s): Mélanie Lebœuf, Stephanie E Vargas-Abonce, Eugénie Pezé-Hedsieck, Edmond Dupont, Lucia Jimenez-Alonso, Kenneth L Moya, Alain Prochiantz
Published in: EMBO Reports, ISSN 1469-3178
Publisher: EMBO Press
DOI: 10.15252/EMBR.202256525

Intellectual Property Rights

Other (1)

Patent application: Stabilized engrailed protein aqueous compositions

Application/Publication number: Stabilized engrailed protein aqueous compositions EP23305048.3
Date: 2023-01-13
Applicant(s): BRAINEVER